Turke & Strauss LLP, a leading data breach law firm, is investigating Puma Biotechnology, Inc. regarding its recent data breach. The Puma Biotechnology data breach involved sensitive personal identifiable information belonging to over 1,900 individuals.
ABOUT PUMA BIOTECHNOLOGY, INC.:
Puma Biotechnology is a biopharmaceutical company specializing in the acquisition and development of novel therapeutics for cancer treatment. Accordingly, Puma Biotechnology develops cancer treating drug candidates that are undergoing or have already completed initial clinical testing, for commercial use. Founded in 2010, Puma Biotechnology has licensed drug candidates from major pharmaceutical brands, including Pfizer. Headquartered in Los Angeles, California, Puma Biotechnology employs over 250 individuals and conducts business globally.
WHAT HAPPENED?
On June 19, 2022, Puma Biotechnology discovered that it had experienced a data breach in which the sensitive personal identifiable information in its systems may have been accessed and acquired. Through its investigation, Puma Biotechnology determined that an unauthorized actor may have accessed and obtained this sensitive information between April 22 and June 19, 2022. On May 17, 2023, Puma Biotechnology began contacting individuals whose information may have been impacted. The type of information exposed includes:
- Name
- Social Security number
- Financial account information
If you received a breach notification letter from Puma Biotechnology:
We would like to speak with you about your rights and potential legal remedies in response to this data breach. Please fill out the form, below, or contact us at (608) 237-1775 or sam@turkestrauss.com.
If you were impacted by the Puma Biotechnology data breach, you may consider taking the following steps to protect your personal information.
- Carefully review the breach notice and retain a copy;
- Enroll in any free credit monitoring services provided by Puma Biotechnology, Inc.;
- Change passwords and security questions for online accounts;
- Regularly review account statements for signs of fraud or unauthorized activity;
- Monitor credit reports for signs of identity theft; and
- Contact a credit bureau(s) to request a temporary fraud alert.